Q1 2024 Holdings
Filed 2024-05-14 | 45 holdings | $107.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Illumina Inc(ILMN) | COM | 452327109 | $16.4M | 119,196 | 15.2% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $12.4M | 368,665 | 11.5% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $10.5M | 263,940 | 9.7% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $5.3M | 436,378 | 4.9% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $5.1M | 1,883,179 | 4.7% |
| Exscientia PLC | ADS | 30223G102 | $4.9M | 859,892 | 4.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.6M | 106,680 | 4.3% |
| Geron Corp(GERN) | COM | 374163103 | $4.4M | 1,324,550 | 4.1% |
| Incyte Corp(INCY) | COM | 45337C102 | $4.2M | 74,022 | 3.9% |
| Merus N V | COM | N5749R100 | $4.0M | 89,516 | 3.7% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $3.6M | 23,022 | 3.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.6M | 219,277 | 2.4% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $2.6M | 118,255 | 2.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $2.4M | 96,100 | 2.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $2.1M | 49,120 | 2.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.1M | 13,600 | 1.9% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.9M | 102,984 | 1.8% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $1.7M | 204,939 | 1.6% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | COM | 097702104 | $1.6M | 1,166,952 | 1.5% |
| Rani Therapeutics Hldgs Inc(RANI) | COM CL A | 753018100 | $1.5M | 493,584 | 1.4% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.5M | 64,200 | 1.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $1.5M | 5,682 | 1.4% |
| Aerovate Therapeutics Inc | COM | 008064107 | $1.4M | 47,936 | 1.3% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $1.0M | 274,488 | 1.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $944.6K | 10,815 | 0.9% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $870.6K | 63,315 | 0.8% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $804.4K | 47,150 | 0.7% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $695.5K | 49,082 | 0.6% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $598.0K | 40,000 | 0.6% |
| Athira Pharma Inc | COM | 04746L104 | $493.2K | 180,000 | 0.5% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $480.6K | 20,987 | 0.4% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $467.7K | 41,950 | 0.4% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $438.8K | 6,750 | 0.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $437.2K | 10,875 | 0.4% |
| Springworks Therapeutics Inc | COM | 85205L107 | $366.7K | 7,450 | 0.3% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $342.2K | 32,470 | 0.3% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $277.9K | 370,950 | 0.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $235.3K | 7,300 | 0.2% |
| Abcellera Biologics Inc(ABCL) | COM | 00288U106 | $230.9K | 50,971 | 0.2% |
| Affimed N V | ORDINARY SHS NEW | N01045207 | $197.4K | 37,247 | 0.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $187.2K | 36,847 | 0.2% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $167.9K | 31,922 | 0.2% |
| Immatics N.v(IMTX) | SHS | N44445109 | $165.0K | 15,700 | 0.2% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $145.9K | 62,106 | 0.1% |
| Galera Therapeutics Inc(GRTX) | COM | 36338D108 | $85.9K | 613,223 | 0.1% |